REGENXBIO Inc. announced the promotion of Curran Simpson from chief technology and operations officer to chief operating officer.
Simpson joined REGENXBIO in 2015 with extensive leadership experience across biopharmaceutical operations, manufacturing, supply chain, research and engineering roles. As chief operating officer, he will have oversight of manufacturing, process development, quality, regulatory, preclinical development and bioanalytical sciences, as well as corporate strategy.
Prior to joining REGENXBIO, he served as the regional supply chain head for North America at GlaxoSmithKline PLC. Prior to that, he was the senior vice president, operations at Human Genome Sciences, as well as the vice president, manufacturing operations at HGS. Prior to HGS, Simpson held various positions with Biogen Inc., Covance Biotechnology Services Inc., Novo-Nordisk Biochem Inc., Genentech Inc. and Genencor Inc.
He received a Master of Science in surface and colloid science from Clarkson University and a Bachelor of Science in chemistry/chemical engineering from Clarkson College of Technology. Read more here.